SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 203.50-1.6%Nov 25 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (14262)2/5/1998 6:59:00 AM
From: Henry Niman  Read Replies (1) of 32384
 
On a positive note, it looks like merger mania in pharmas is beginning to spill over into Biotechs:

Pharmacopeia to acquire Molecular

PRINCETON, N.J., Feb 4 (Reuters) - Pharmacopeia Inc and
Molecular Simulations Inc said Wednesday that they have signed
a definitive deal in which Pharmacopeia will acquire MSI for
about 7.0 million newly-issued Pharmacopeia common shares.
In a statement, Pharmacopeia and MSI said it will also
convert the outstanding MSI options into Pharmacopeia options,
potentially resulting in the net issuance of another 1.5
million new Pharmacopeia shares.
Based on the $16.50 per share closing price of Pharmacopeia
common stock on February 3, 1998, the transaction is valued at
approximately $140 million.
MORE
Rtr 17:45 02-04-98
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext